Attached files
file | filename |
---|---|
EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - QUANTRX BIOMEDICAL CORP | ex31.htm |
10-K/A - AMENDMENT NO. 1 TO FORM 10-K - QUANTRX BIOMEDICAL CORP | qtxb10ka_dec312016.htm |
Exhibit 32
CERTIFICATION PURSUANT TO 18 U.S.C. Sec.1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying
Amendment No. 1 to the Annual Report of QuantRx Biomedical
Corporation (the "Company") on Form 10-K/A for the period ending December
31, 2016 as filed with the Securities and Exchange Commission on or
about the date hereof (the "Report"), the undersigned, Shalom Hirschman, Principal
Executive and Principal Financial and Accounting Officer of the
Company, certifies, to my best knowledge and belief, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies
with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) The information contained in
the Report fairly presents, in all material respects, the financial
condition and result of operations of the Company.
|
Date: October 5, 2017
|
/s/ Shalom Hirschman
|
|
|
Shalom Hirschman
Principal Executive and Financial Officer
|